SYNH News and Press, Syneos Health Inc. From 07/22/23

2023-07-22 05:30:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Economic resiliency, s...

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) , a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, is reporting that an arbitration panel has found t...

2023-07-16 07:00:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Mid cap stocks generat...

NEW YORK, NY / ACCESSWIRE / July 10, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: American Equity Investment Life Holdi...

MORRISVILLE, N.C., July 10, 2023 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced the appointment of Hillary Bochniak as Chief Human Resources Officer, effective July 10, 2023. Ms. Bochniak joins...

2023-07-02 12:00:52 ET The tables have turned for Contract services organizations (CROs), with their toplines under pressure amid a post-pandemic drop in demand for clinical trial services worsened by biotech’s funding woes. The group offers clinical trial management services for...

2023-06-30 17:07:45 ET Summary Syneos Health received an acquisition offer from a PE consortium of c.$7.1 billion. The transaction involves an all-cash consideration of $43.00 per share, a 1.7% premium over SYNH's stock price at the time of the offer. Shareholders are yet to v...

MORRISVILLE, N.C., June 26, 2023 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced a strategic partnership with uMotif, a clinical trial technology company putting the patient at the center of research....

2023-05-26 07:00:26 ET FivepHusion has collaboration with Treehill Partners, a New York-based strategic and financial advisory firm specializing in healthcare industry transactions, and Syneos Health ( NASDAQ: SYNH ) to develop and bring a novel, enhanced chemotherapeutic p...

MORRISVILLE, N.C., May 25, 2023 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced the appointment of Batisha Anson to the newly created role of Global Head of Patient Diversity and Health Equity. In thi...